Emergent BioSolutions to Participate in Investor Conferences

Rhea-AI Summary

Emergent BioSolutions (NYSE: EBS) announced participation in several investor conferences in August and September 2022. Key events include the 12th Annual Midwest IDEAS Investor Conference on August 24, a fireside chat at the Wells Fargo 2022 Healthcare Conference and Leveraged Finance Conference on September 8, and the Morgan Stanley 20th Annual Global Healthcare Conference from September 12-14. Webcast presentations will cover recent business developments and financial results, available live and on replay from the Emergent website.

GAITHERSBURG, Md., Aug. 10, 2022 (GLOBE NEWSWIRE) -- Emergent BioSolutions Inc. (NYSE: EBS) announced today that members of the company’s executive management team will participate in the following investor conferences:

• 12^th Annual Midwest IDEAS Investor Conference
  Chicago, IL
  August 24, 2022 – presentation scheduled at 5:15 PM central time
  https://www.wsw.com/webcast/threepa38/ebs/2021448
  

• Wells Fargo 2022 Healthcare Conference
  Boston, MA
  September 8, 2022 – fireside chat scheduled at 9:10 AM eastern time

• Wells Fargo 2022 Leveraged Finance Conference
  Nashville, TN
  September 8, 2022 – fireside chat scheduled at 2:30 PM central time

• Morgan Stanley 20^th Annual Global Healthcare Conference
  New York, NY
  September 12-14, 2022 – presentation date and time will be updated on the Emergent website as the information becomes available

For conferences where a presentation is planned, the company’s webcast presentation may include a discussion of the company's recent business developments as well as its financial results and guidance. The webcasts will be available both live, if possible, and by replay, and will be accessible from the Emergent website.

About Emergent BioSolutions
At Emergent, our mission is to protect and enhance life. For over 20 years, we’ve been at work defending people from things we hope will never happen—so we are prepared, just in case they ever do. We provide solutions for complex and urgent public health threats through a portfolio of vaccines and therapeutics that we develop and manufacture for governments and consumers. We also offer a range of integrated contract development and manufacturing services for pharmaceutical and biotechnology customers. To learn more about how we plan to protect or enhance 1 billion lives by 2030, visit our website and follow us on LinkedIn, Twitter, and Instagram.

Investor Contact:
Robert G. Burrows
Vice President, Investor Relations
240-631-3280
burrowsr@ebsi.com  

Media Contact:
Matt Hartwig
Senior Director, Media Relations
mediarelations@ebsi.com

FAQ

What are the upcoming investor conferences for Emergent BioSolutions (EBS) in August 2022?

Emergent BioSolutions will participate in the 12th Annual Midwest IDEAS Investor Conference on August 24, 2022.

When is Emergent BioSolutions (EBS) presenting at the Wells Fargo Healthcare Conference?

Emergent BioSolutions will have a fireside chat at the Wells Fargo 2022 Healthcare Conference on September 8, 2022, at 9:10 AM Eastern Time.

What is the schedule for the Wells Fargo 2022 Leveraged Finance Conference for Emergent BioSolutions (EBS)?

Emergent BioSolutions will participate in the Wells Fargo 2022 Leveraged Finance Conference on September 8, 2022, at 2:30 PM Central Time.

When will Emergent BioSolutions (EBS) present at the Morgan Stanley Global Healthcare Conference?

The Morgan Stanley 20th Annual Global Healthcare Conference takes place from September 12-14, 2022, with presentation dates to be updated on the Emergent website.

Where can I find the webcasts for Emergent BioSolutions (EBS) investor presentations?

Webcasts for Emergent BioSolutions presentations will be available live and for replay on the Emergent website.